Carcinoid syndrome is a paraneoplastic syndrome.
Pathophysiology
The syndrome is caused by the secretion of substances from a
carcinoid tumour. The primary mediators are serotonin (a neurotransmitter) and kallikrein (an enzyme). Kallikrein catalyses conversion of kininogen to lysyl-bradykinin. This becomes bradykinin, a potent vasodilator.
There are elevated plasma histamine levels, but the mechanism through which this occurs is unclear.
- Serotonin disturbs GI motility.
- Bradykinin causes facial vasodilation and flushing.
- Histamine causes bronchoconstriction.
- Serotonin promotes cardiac fibrosis, particularly at the tricuspid and pulmonary valves.
Symptoms
- Facial flushing (due to vasodilation of superficial vessels in the skin)
- GI disturbances, especially diarrhoea, nausea, vomiting
- Abdominal pain, cramps
- Wheezing (due to narrowed bronchi)
Complications
Investigation findings
- Fibrosis of the valvular endocardium
- Secondary restrictive cardiomyopathy